0

Selexis SA – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Publisher Name :
Date: 16-May-2017
No. of pages: 39

Summary

Selexis SA (Selexis) is a biotechnology company that develops technologies for drug discovery, cell line development and manufacture of biopharmaceutical products. The company develops a pipeline of technologies such as Selexis Genetic Elements, Selexis SUREtech Vectors, Selexis SUREfection Procedures, Selexis SURE CHO-M Cell Line and Selexis SURE CHO-Mplus Libraries by utilizing its technology platform. Its services include genome characterization, lead identification, cell line development, MAb humanization and licensing. Selexis’ activities include cell line development, lead identification, and genome characterization. The company generates mammalian cell line in bioproduction. It caters products and services to bioproduction, biopharmaceuticals, biotechnology, contract manufacturing, clinical research, diagnostics, pharmaceutical, vaccines and other industries. Selexis is headquartered in Geneva, Switzerland.

Selexis SA – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

– Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
– Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
– Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
– Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
– Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
– Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
– Business Description – A brief description of the company’s operations.
– Key Employees – A list of the key executives of the company.
– Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
– Key Competitors – A list of the key competitors of the company.
– Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
– The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
– The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
– Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
– The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
– Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
– Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table of content
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Selexis SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Selexis SA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Selexis SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Selexis SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Selexis SA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Selexis SA, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
Selexis Enters into Agreement with OSE Immunotherapeutics 12
Selexis Enters into Agreement with Xencor 12
Complix Partners with Selexis 13
Faron Pharma Enters into Agreement with Selexis 14
JHL Biotech Enters Into Agreement With Selexis For Drug Development 15
Selexis Enters Into Partnership Agreement With Fusion Antibodies 16
Oncobiologics Enters into Research Agreement with Selexis 17
Licensing Agreements 17
Zymeworks Enters into Licensing Agreement with Selexis 17
Oncobiologics Amends its Licensing Agreement with Selexis for ONS-1045 18
Oncobiologics Amends its Licensing Agreement with Selexis for ONS-1050 19
Oncobiologics Amends its Licensing Agreement with Selexis for ONS-3010 20
Coherus BioSciences Enters into Licensing Agreement with Selexis 22
ImmuNext Enters into Licensing Agreement with Selexis 23
Pieris Pharma Enters into Licensing Agreement with Selexis 23
Turgut Ilaclari Enters into Licensing Agreement with Selexis 24
Progenics Pharma Enters into Licensing Agreement with Selexis 25
Laboratorios Liomont Enters into Licensing Agreement with Selexis 26
Opthea Enters Into Licensing Agreement With Selexis For Wet AMD Product 26
Selexis Expands License Agreement With Amgen 27
Selexis Enters Into Licensing Agreement With CSL 28
Selexis Enters Into Licensing Agreement With Neogenix Oncology 29
Asset Transactions 29
Agenus Enters Acquires Rights to Cell Line Development Technology from Selexis 29
Ligand Pharma Acquires Financial Rights to More Than 15 Biologic Development Programs from Selexis for USD4 Million 30
Ligand Pharma Acquires Financial Rights To Over 15 Biologic Development Programs Of Selexis For Up To US$4.5 Million 31
Selexis SA - Key Competitors 33
Key Employees 34
Locations And Subsidiaries 35
Head Office 35
Other Locations & Subsidiaries 35
Recent Developments 36
Strategy And Business Planning 36
May 11, 2017: Selexis Opens New World-Class Laboratory Facility and Corporate Headquarters in Geneva, Switzerland 36
Product News 38
Mar 20, 2017: Selexis Announces Launch of Novel Cell Selection Platform Designed to Help Advance Difficult-to-Express Protein Therapeutics to the Clinic 38
Appendix 39
Methodology 39
About GlobalData 39
Contact Us 39
Disclaimer 39

List of Tables
Selexis SA, Pharmaceuticals & Healthcare, Key Facts 1
Selexis SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Selexis SA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Selexis SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Selexis SA, Deals By Therapy Area, 2011 to YTD 2017 9
Selexis SA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Selexis Enters into Agreement with OSE Immunotherapeutics 12
Selexis Enters into Agreement with Xencor 12
Complix Partners with Selexis 13
Faron Pharma Enters into Agreement with Selexis 14
JHL Biotech Enters Into Agreement With Selexis For Drug Development 15
Selexis Enters Into Partnership Agreement With Fusion Antibodies 16
Oncobiologics Enters into Research Agreement with Selexis 17
Zymeworks Enters into Licensing Agreement with Selexis 17
Oncobiologics Amends its Licensing Agreement with Selexis for ONS-1045 18
Oncobiologics Amends its Licensing Agreement with Selexis for ONS-1050 19
Oncobiologics Amends its Licensing Agreement with Selexis for ONS-3010 20
Coherus BioSciences Enters into Licensing Agreement with Selexis 22
ImmuNext Enters into Licensing Agreement with Selexis 23
Pieris Pharma Enters into Licensing Agreement with Selexis 23
Turgut Ilaclari Enters into Licensing Agreement with Selexis 24
Progenics Pharma Enters into Licensing Agreement with Selexis 25
Laboratorios Liomont Enters into Licensing Agreement with Selexis 26
Opthea Enters Into Licensing Agreement With Selexis For Wet AMD Product 26
Selexis Expands License Agreement With Amgen 27
Selexis Enters Into Licensing Agreement With CSL 28
Selexis Enters Into Licensing Agreement With Neogenix Oncology 29
Agenus Enters Acquires Rights to Cell Line Development Technology from Selexis 29
Ligand Pharma Acquires Financial Rights to More Than 15 Biologic Development Programs from Selexis for USD4 Million 30
Ligand Pharma Acquires Financial Rights To Over 15 Biologic Development Programs Of Selexis For Up To US$4.5 Million 31
Selexis SA, Key Competitors 33
Selexis SA, Key Employees 34
Selexis SA, Subsidiaries 35

List of Figures
Selexis SA, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
Selexis SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
Selexis SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
Selexis SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
Selexis SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Selexis SA, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 7
Selexis SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Selexis SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9

News

  • Understanding the Need For Travel Vaccination
  • If you are getting ready for a particular trip that can see you away from your house for about a month or so, then it is necessary for you to take the help of travel vaccinations. Not ...
  • The Work Of The Ophthalmology Specialist
  • When we consider ophthalmology as a branch of science, it is actually about the treatment as well as getting to diagnose the different kinds of diseases and the disorder that is to ...
  • The Process Of Dental Implants And The Subsequent Recovery
  • In the United States of America, the fear of going to a dentist happens to rank number one on the list of children as well as adults. Most of the people are actually concerned when ...
  • The medication that can help the rural population
  • It is not always that you get to see world class hospitals in the rural areas, be it America or any other country. Hence, it is important that people actually take the help of tele-medication, ...
  • The Future of Telemedicine & Its Use
  • When talking about telemedicine, you do get to realize that it is the healthcare of the future. Most of the people do not realize the implications, and for more so the time, telemedicine ...

Get Updates

Share This Post

Recent Posts

© 2021 RnR Company Profiles. All rights reserved.